Philadelphia, Pennsylvania — The NFL has put its Jalen Hurts review in writing. In a November 6 letter to U.S. Senator Lisa Blunt Rochester, released by her office on Friday, November 13, NFL executive vice president Jeff Miller said that, as outlined in the league and NFL Players Association's collective bargaining agreement, 'mutually agreed-upon independent medical experts will review the matter and share their conclusions and recommendations with both parties.'
Miller also told the senator the league has tracked clotting disorders among players every season for at least a decade through a subcommittee of its General Medical Committee, sharing that information with the NFLPA, and that after the joint review the league and union 'will consider appropriate next steps, including whether this case points to a need for additional league-wide guidance.' Blunt Rochester, who lost her husband Charles after blood clots reached his heart and lungs following an Achilles injury sustained playing basketball, had written to Commissioner Roger Goodell on October 21 asking whether a standard clot protocol exists and who cleared Hurts to play and to fly.
What the letter does not do is start the review. Five weeks after Hurts played in London, the league and the union are still working to hammer out the parameters of the investigation, as ESPN's Tim McManus reported and NBC Sports noted on November 14, and the NFLPA has not invoked its right to launch an investigation under Article 39 of the CBA. The union had called on October 20 for a full investigation, saying the league had previously told it that it did not plan to review the care Hurts received. A person with knowledge of the situation told the Associated Press the Eagles will not be disciplined over his care.
The timeline under review is not in dispute: a superficial clot was found on a Cleveland Clinic ultrasound in London on October 10; Hurts was cleared and played the full October 11 loss to Jacksonville; a follow-up ultrasound on October 14 showed the clot had moved; he went on injured reserve on October 17; and the diagnosis was upgraded on October 19 to deep vein thrombosis and bilateral pulmonary emboli. He is on blood thinners, barred from contact, and, per Miller's letter, clinically stable with no significant functional limitations. No review has found that the Eagles or their medical staff acted improperly — the expert review has not yet begun.
Why it matters: the league has written protocols for concussions, heat and emergency care, but by its own account each club's medical staff handles a suspected blood clot case by case. Whether the Hurts case produces the league-wide guidance Miller floated is now the question the review has to answer.
Sources: Senator Lisa Blunt Rochester's office, press release publishing Jeff Miller's November 6 NFL letter (November 13, 2026); NBC Sports / Pro Football Talk (November 14, 2026); Essentially Sports (November 14, 2026); Athlitical, including AP reporting (November 15, 2026).
